
The Top A.I. Stories of 2022
AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.
AI drives new signal-detection efforts in Alzheimer’s and ALS.
The two technologies are helping HCPs spread information and collect data in new ways.
Jason Smith discusses his work with AI-based data platforms.
What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.
Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.